A new medication could possibly treat patients who have tested positive for the coronavirus which could mean the beginning of the end of the pandemic, as revealed by Fox News medical contributor Dr. Marc Siegal.
First-stage testing has already begun on the experimental COVID-19 pill called Molnupiravir, by Merck and Ridgeback Biotherapeutics, and tests are showing some promising signs of effectiveness in reducing symptoms of the virus in patients.
"It may be the holy grail on this because it was just studied in phase two trials and it literally stopped the virus in its tracks," he explained. "And there wasn't any virus found in the patients that were studied."
The drug would function as an at-home, five-day treatment, similar to Tamiflu, to stop the virus from reproducing before causing major damage. Siegel said the therapeutic could come to market in as little as four to five months.
— Merck (@Merck) March 6, 2021
The doctor said even though only 182 patients were studied during testing so far, the pill could still be "very promising" for thousands of people.
"This might be the future once the vaccine really gets control over the pandemic and we just start seeing isolated cases," he said. "By then, this drug might be ready and this might be the drug for over the next several months."
Siegel predicts the U.S. will be coronavirus-free by the summer, making the Molnupiravir treatment "very helpful" for managing isolated cases. He believes this is the first pill that we can use against COVID as a therapeutic.